Search research articles
Contact Us
Filters
Showing results (791-800 of 1,011) with videos related to
Page
of 102
Sort By:
Kidney International
|
March 23, 2019
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease
Ron T Gansevoort, Maatje D A van Gastel, Arlene B Chapman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 22, 2011
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study
Vicente E Torres, Esther Meijer, Kyongtae T Bae, et al.
Clinical Pharmacology and Therapeutics
|
July 3, 2009
Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order
J A Johnson, Y Gong, K R Bailey, et al.
The Oncologist
|
February 6, 2023
Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy
Thomas M Atkinson, Jennifer L Hay, Soo Young Kim, et al.
Clinical and Translational Science
|
March 8, 2016
Melatonin Pathway and Atenolol-Related Glucose Dysregulation: Is There a Correlation?
S W Chang, Y Gong, C W McDonough, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma
David B Solit, Iman Osman, David Polsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 23, 2013
Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease
Kyungsoo Bae, Bumwoo Park, Hongliang Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1996
Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma
A A Jakubowski, D F Bajorin, M A Templeton, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
April 30, 2015
Psychiatric disorders in children and adolescents 24 months after mild traumatic brain injury
Jeffrey E Max, Keren Friedman, Elisabeth A Wilde, et al.
JCO Precision Oncology
|
February 9, 2022
Elevated Levels of <i>BRAF</i> Mutant Circulating Tumor DNA and Circulating Hepatocyte Growth Factor Are Associated With Poor Prognosis in Patients With Metastatic Melanoma
William Lu, Luciana Burton, James Larkin, et al.
Page
of 102
Search research articles
Search
Showing results (791-800 of 1,011) with videos related to
Sort By:
Page
of 102
Kidney International
|
March 23, 2019
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease
Ron T Gansevoort, Maatje D A van Gastel, Arlene B Chapman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 22, 2011
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study
Vicente E Torres, Esther Meijer, Kyongtae T Bae, et al.
Clinical Pharmacology and Therapeutics
|
July 3, 2009
Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order
J A Johnson, Y Gong, K R Bailey, et al.
The Oncologist
|
February 6, 2023
Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy
Thomas M Atkinson, Jennifer L Hay, Soo Young Kim, et al.
Clinical and Translational Science
|
March 8, 2016
Melatonin Pathway and Atenolol-Related Glucose Dysregulation: Is There a Correlation?
S W Chang, Y Gong, C W McDonough, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma
David B Solit, Iman Osman, David Polsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 23, 2013
Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease
Kyungsoo Bae, Bumwoo Park, Hongliang Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1996
Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma
A A Jakubowski, D F Bajorin, M A Templeton, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
April 30, 2015
Psychiatric disorders in children and adolescents 24 months after mild traumatic brain injury
Jeffrey E Max, Keren Friedman, Elisabeth A Wilde, et al.
JCO Precision Oncology
|
February 9, 2022
Elevated Levels of <i>BRAF</i> Mutant Circulating Tumor DNA and Circulating Hepatocyte Growth Factor Are Associated With Poor Prognosis in Patients With Metastatic Melanoma
William Lu, Luciana Burton, James Larkin, et al.
Page
of 102